Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
about
Interventional Nanotheranostics of Pancreatic Ductal AdenocarcinomaNanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein traffickingTowards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancerDeveloping a highly stable PLGA-mPEG nanoparticle loaded with cisplatin for chemotherapy of ovarian cancerLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy.Liposomal Formulations in Clinical Use: An Updated Review.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicCo-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapyInteraction of liposome-encapsulated cisplatin with biomolecules.Nanocarriers for delivery of platinum anticancer drugs.Antibacterial properties of silver nanoparticles in three different sizes and their nanocomposites with a new waterborne polyurethane.Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapyNanotechnology in oncology: Characterization and in vitro release kinetics of cisplatin-loaded albumin nanoparticles: Implications in anticancer drug delivery.Rapid detection and destruction of squamous cell carcinoma of the head and neck by nano-quadrapeutics.Treatment of pleural malignancies by photo-induction combined to systemic chemotherapy: Proof of concept on rodent lung tumors and feasibility study on porcine chest cavities.New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect.Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinomaScience and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes.Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer.Emergence and Utility of Nonspherical Particles in BiomedicineA platelet-mimetic paradigm for metastasis-targeted nanomedicine platformsPotential for enhancing external beam radiotherapy for lung cancer using high-Z nanoparticles administered via inhalationCell-centric view of apoptosis and apoptotic cell death-inducing antitumoral strategiesEstablishment of an Experimental Breast Cancer ZHENG Model and Curative Effect Evaluation of Zuo-Jin Wan.Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapyClinical developments in nanotechnology for cancer therapy.The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.Targeting and delivery of platinum-based anticancer drugs.Exosomes in tumor microenvironment influence cancer progression and metastasis.Application of liposomal technologies for delivery of platinum analogs in oncology.Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma.Target-selective delivery and activation of platinum-based anticancer agents.Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer.Nanoparticle formulations of cisplatin for cancer therapy.
P2860
Q26744830-0EC08916-8792-4ECF-98DA-B6A8E94FAA1CQ27011482-3534124D-8870-42D1-AAF4-05012C22DC07Q28291499-F4EDF1D4-1E15-43C6-A512-C2F07EAA3395Q28477234-63375807-BF77-47A6-BFF2-54585F37864CQ30366990-84D05C6D-3BC9-4BA8-A7CF-DECF396B331FQ31106992-F56307B2-95C3-4518-802A-9428BA234054Q33827802-F8A206A6-9B3A-4345-9F5E-B8C70135DFD3Q33850427-B97236B5-35A1-4820-9A39-872C132A00EFQ33911056-400D1843-628B-42AB-A5BB-F9B82E0DD5C9Q33915162-651C376B-B6BF-4CDF-9602-34B3BF428A14Q34275000-03E0C324-AFF0-4ED3-9BA0-F8C5446C6032Q34295156-C4347C39-AAE7-4753-97B5-DB86EB8D6E2FQ34338695-C34780AA-5F3F-468E-8A5F-9B5B2086D90BQ34440024-141EA6B3-81E6-4EE1-AF98-C26E7AEBB85BQ34680322-B3437E94-C469-4F24-BE2E-013F85F500E8Q34791190-C8B95CC7-CF75-4AAE-AE24-E68A61612742Q35157105-7E28F4E5-7700-4616-904B-E242674E9DDCQ35560212-E2F3042F-6032-4B73-81D8-8E1EA4B9E253Q35790604-8FF81E49-128B-49F4-8A58-27F769AFE87BQ35821336-B5E297BA-A1A6-4116-905D-79CD2451FEFAQ36014101-198BF3F0-7A91-4ACE-A86B-AF5D208F8D7CQ36394925-D09469D8-6DBE-4A1B-A315-21A92FD4E6BEQ36682970-D2268B29-09D0-40D1-874B-4C11CBCA2BEEQ36723759-7B173B23-BD23-4A03-9560-31221801B69CQ36892538-B1B5A12F-6102-4DD7-AEA9-CB0A5B2BB82BQ36949458-9BFFBF99-B275-428A-9324-0140C2D0360DQ37098720-B809B51E-071C-48FD-97F9-03835D975371Q37129849-8E795F3E-3679-4461-92D7-482BF2180D17Q37380009-D84F17DC-B0F4-43FF-B7CC-26F709DE2187Q37625480-4F65D359-6668-43C7-A908-85043CE0778AQ37765187-92461195-E336-4BB5-BE8D-530453759342Q37815479-5E53516C-DBA8-4C83-A119-D3DB8E07B93EQ38050063-6AB403A3-9CCA-41B8-9CF7-23A71FFF8B1AQ38091978-D97A5251-3B50-4B87-A9D2-F2813C17DF90Q38136184-BBFC04EB-6D5C-48AA-943C-A873F4DF98BCQ38275454-C607DFBE-B90A-408F-BBFF-EE2A24CCE8C1Q38523600-7D25C2D8-89D0-4EE3-80F2-3F18AD01F523Q38546964-F905E1F1-568F-4E6A-9934-53426ADC682BQ38633157-CFED3FB0-C6A2-4339-85A2-3B76CEFED86CQ38723829-E4F6CBB4-9383-4BB7-BEA2-3AA989F689E1
P2860
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
@en
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
@nl
type
label
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
@en
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
@nl
prefLabel
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
@en
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
@nl
P2860
P1476
Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
@en
P2093
Teni Boulikas
P2860
P304
P356
10.1517/13543780903114168
P407
P577
2009-08-01T00:00:00Z